THURSDAY, Dec. 26, (2024 HealthDay News)  — The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for people living with Type 2 diabetes. Liraglutide, the generic for Victoza, is similar to semaglutide, the active ingredient inContinue Reading

MONDAY, Dec. 23, 2024 (HealthDay News) — Bedtime stories are a time-honored means of helping kids calm down and get a good night’s sleep. But these fairy tales can also serve another less obvious purpose — teaching children about the benefits of good sleep. Analysis of four traditional children’s talesContinue Reading